Single nucleotide polymorphisms in the anti-Müllerian hormone signalling pathway do not determine high or low response to ovarian stimulation

Reproductive BioMedicine Online

Volumn 21, Issue 5, 2010, Pages 616-623

  Hanevik, Hans Ivar ^a   Hilmarsen, Hilde Tveitan ^b   Skjelbred, Camilla Furu ^b   Tanbo, Tom ^c   Kahn, Jarl A ^a  

^a Telemark Hospital   (Norway)

^b TELEMARK HOSPITAL   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

anti M llerian hormone; FSH; IVF; ovarian response; polymorphisms

Indexed keywords

HUMAN MENOPAUSAL GONADOTROPIN; MUELLERIAN INHIBITING FACTOR; NAFARELIN; NAFARELIN ACETATE; RECOMBINANT FOLLITROPIN;

ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD SAMPLING; BODY MASS; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; OVARY; PREDICTION; RETROSPECTIVE STUDY; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; STIMULATION;

ADULT; ANTI-MULLERIAN HORMONE; CASE-CONTROL STUDIES; FEMALE; HUMANS; OVULATION INDUCTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RETROSPECTIVE STUDIES; SIGNAL TRANSDUCTION;

EID: 78049454267     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rbmo.2010.05.021     Document Type: Article

References (35)

1. S.K. Achrekar, D.N. Modi, S.K. Desai, V.S. Mangoli, R.V. Mangoli, and S.D. Mahale Follicle-stimulating hormone receptor polymorphism (Thr307Ala) is associated with variable ovarian response and ovarian hyperstimulation syndrome in Indian women Fertil. Steril. 91 2009 432 439
2. C.Y. Andersen, and A.G. Byskov Oestradiol and regulation of anti-Mullerian hormone, inhibin-A, and inhibin-B secretion: analysis of small antral and preovulatory human follicles' fluid J. Clin. Endocrinol. Metab. 91 2006 4064 4069
3. D.H. Barad, A. Weghofer, and N. Gleicher Comparing anti-Mullerian hormone (AMH) and follicle-stimulating hormone (FSH) as predictors of ovarian function Fertil. Steril. 91 2009 1553 1555
4. J.C. Barrett, B. Fry, J. Maller, and M.J. Daly Haploview: analysis and visualization of LD and haplotype maps Bioinformatics 21 2005 263 265
5. H.M. Behre, R.R. Greb, and A. Mempel Significance of a common single nucleotide polymorphism in exon 10 of the follicle-stimulating hormone (FSH) receptor gene for the ovarian response to FSH: a pharmacogenetic approach to controlled ovarian hyperstimulation Pharmacogenet. Genomics 15 2005 451 456
6. F.J. Broekmans, J. Kwee, D.J. Hendriks, B.W. Mol, and C.B. Lambalk A systematic review of tests predicting ovarian reserve and IVF outcome Hum. Reprod. Update 12 2006 685 718
7. S.L. Broer, B.W. Mol, D. Hendriks, and F.J. Broekmans The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count Fertil. Steril. 91 2009 705 714
8. C. Daelemans, G. Smits, and V. de Maertelaer Prediction of severity of symptoms in iatrogenic ovarian hyperstimulation syndrome by follicle-stimulating hormone receptor Ser680Asn polymorphism J. Clin. Endocrinol. Metab. 89 2004 6310 6315
9. F. de Castro, F.J. Moron, and L. Montoro Human controlled ovarian hyperstimulation outcome is a polygenic trait Pharmacogenetics 14 2004 285 293
10. A. Delvigne Symposium: Update on prediction and management of OHSS. Epidemiology of OHSS Reprod. Biomed. Online 19 2009 8 13
11. N. di Clemente, B. Goxe, J. Remy, R. Cate, N. Josso, B. Vigier, and R. Salesse Inhibitory effect of AMH upon the expression of aromatase and LH receptors by cultured granulosa cells of rat and porcine immature ovaries Endocrine 2 1994 553 558
12. W.D. Dupont, and W.D. Plummer Jr. Power and sample size calculations. A review and computer program Control. Clin. Trials 11 1990 116 128
13. A.L. Durlinger, P. Kramer, and B. Karels Control of primordial follicle recruitment by anti-Mullerian hormone in the mouse ovary Endocrinology 140 1999 5789 5796
14. A.L. Durlinger, M.J. Gruijters, and P. Kramer Anti-Mullerian hormone inhibits initiation of primordial follicle growth in the mouse ovary Endocrinology 143 2002 1076 1084
15. A. Enskog, M. Henriksson, M. Unander, L. Nilsson, and M. Brannstrom Prospective study of the clinical and laboratory parameters of patients in whom ovarian hyperstimulation syndrome developed during controlled ovarian hyperstimulation for in vitro fertilization Fertil. Steril. 71 1999 808 814
16. H. Falconer, E. Andersson, A. Aanesen, and G. Fried Follicle-stimulating hormone receptor polymorphisms in a population of infertile women Acta Obstet. Gynecol. Scand. 84 2005 806 811
17. R. Fanchin, L.M. Schonauer, C. Righini, N. Frydman, R. Frydman, and J. Taieb Serum anti-Mullerian hormone dynamics during controlled ovarian hyperstimulation Hum. Reprod. 18 2003 328 332
18. P. Fedorcsak, P.O. Dale, and R. Storeng Impact of overweight and underweight on assisted reproduction treatment Hum. Reprod. 19 2004 2523 2528
19. H.A. Ingraham, Y. Hirokawa, and L.M. Roberts Autocrine and paracrine Mullerian inhibiting substance hormone signaling in reproduction Recent Prog. Horm. Res. 55 2000 53 67 discussion 67-58
20. E. Kerkelä, H. Skottman, B. Friden, K. Bjuresten, J. Kere, and O. Hovatta Exclusion of coding-region mutations in luteinizing hormone and follicle-stimulating hormone receptor genes as the cause of ovarian hyperstimulation syndrome Fertil. Steril. 87 2007 603 606
21. M.E. Kevenaar, A.P. Themmen, and J.S. Laven Anti-Mullerian hormone and anti-Mullerian hormone type II receptor polymorphisms are associated with follicular phase oestradiol levels in normo-ovulatory women Hum. Reprod. 22 2007 1547 1554
22. E.R. Klinkert, F.J. Broekmans, C.W. Looman, J.D. Habbema, and E.R. te Velde Expected poor responders on the basis of an antral follicle count do not benefit from a higher starting dose of gonadotrophins in IVF treatment: a randomized controlled trial Hum. Reprod. 20 2005 611 615
23. A. La Marca, F.J. Broekmans, A. Volpe, B.C. Fauser, and N.S. Macklon Anti-Mullerian hormone (AMH): what do we still need to know? Hum. Reprod. 24 2009 2264 2275
24. A. La Marca, G. Sighinolfi, and D. Radi Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART) Hum. Reprod. 16 2010 113 130
25. T.H. Lee, C.H. Liu, and C.C. Huang Serum anti-Mullerian hormone and oestradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles Hum. Reprod. 23 2008 160 167
26. S.M. Nelson, R.W. Yates, and H. Lyall Anti-Mullerian hormone-based approach to controlled ovarian stimulation for assisted conception Hum. Reprod. 24 2009 867 875
27. M. Perez Mayorga, J. Gromoll, H.M. Behre, C. Gassner, E. Nieschlag, and M. Simoni Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype J. Clin. Endocrinol. Metab. 85 2000 3365 3369
28. B. Rizk, and M. Aboulghar Classification, pathophysiology and management of ovarian hyperstimulation syndrome P. Brinsden, A Textbook of In Vitro Fertilization and Assisted Reproduction: The Bourne Hall Guide to Clinical and Laboratory Practice 1999 The Parthenon Publishing Group Lancs./New York 131 155
29. S. Rodriguez, T.R. Gaunt, and I.N. Day Hardy-Weinberg equilibrium testing of biological ascertainment for Mendelian randomization studies Am. J. Epidemiol. 169 2009 505 514
30. P. Saldeen, K. Kallen, and P. Sundstrom The probability of successful IVF outcome after poor ovarian response Acta Obstet. Gynecol. Scand. 86 2007 457 461
31. D.B. Seifer, D.T. MacLaughlin, B.P. Christian, B. Feng, and R.M. Shelden Early follicular serum mullerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles Fertil. Steril. 77 2002 468 471
32. M. Simoni, C.B. Tempfer, B. Destenaves, and B.C. Fauser Functional genetic polymorphisms and female reproductive disorders: part I: polycystic ovary syndrome and ovarian response Hum. Reprod. Update 14 2008 459 484
33. T. Tanbo, E. Kjekshus, and P.O. Dale Intracytoplasmic sperm injection Tidsskr. Nor. Laegeforen. 118 1998 864 869
34. C. Weenen, J.S. Laven, and A.R. Von Bergh Anti-Mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment Mol. Hum. Reprod. 10 2004 77 83
35. C.H. Wu, Y.C. Chen, H.H. Wu, J.G. Yang, Y.J. Chang, and H.D. Tsai Serum anti-Mullerian hormone predicts ovarian response and cycle outcome in IVF patients J. Assist. Reprod. Genet. 26 2009 383 389